Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons
September 4, 2019
Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.
Officially sworn in as Governor-General on 1 July 2019, His Excellency says he and Mrs Hurley are proud to be involved with the Institute.
“Linda and I are proud to be Patrons of Children’s Cancer Institute.
“We know that cancer can strike anyone, at any age, and that nearly three children in Australia die from cancer every week.
“Just thinking about it is takes the breath away. Each and every week, young lives lost, leaving parents, families and loved ones devastated. It is a tragedy. But it is a tragedy that the team at Children’s Cancer Institute are working to address. Their vision of saving the lives of all children with cancer may be ambitious but so too is their dedication and commitment.
“We are delighted to be involved with the Institute and look forward to supporting their efforts over the next five years.”
Professor Michelle Haber AM, Executive Director of Children’s Cancer Institute, warmly welcomed His Excellency and Mrs Hurley as Patrons.
“On behalf of everyone here at Children’s Institute, we are delighted to welcome His Excellency and Mrs Hurley on board as Patrons.”
“As part of our team, their passion, leadership and advocacy will be invaluable to us in our mission to cure all children of cancer.”
Find out more about the Governor-General at https://www.gg.gov.au/about-governor-general/governor-generals-biography
About Children’s Cancer Institute
Originally founded by two fathers of children with cancer in 1976, Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to research into the causes, prevention and cure of childhood cancer. Forty years on, our vision is to save the lives of all children with cancer and improve their long-term health, through research. The Institute has grown to now employ nearly 300 researchers, operational staff and students, and has established a national and international reputation for scientific excellence.
Our focus is on translational research, and we have an integrated team of laboratory researchers and clinician scientists who work together in partnership to discover new treatments which can be progressed from the lab bench to the beds of children on wards in our hospitals as quickly as possible. These new treatments are specifically targeting childhood cancers, so we can develop safer and more effective drugs and drug combinations that will minimise side-effects and ultimately give children with cancer the best chance of a cure with the highest possible quality of life.